Supportive Oligonucleotide Technique (SOT)

Supportive Oligonucleotide Technique (SOT)

(A PRIVATE MEMBERSHIP MEDICAL ASSOCIATION) RGCC-labs uses mRNA expression fingerprinting in order to identify certain gene expression patterns as targets, but without influence to the genetic structure (epigenetic). Based on this analysis RGCC-Labs uses the mRNA analysis of each individuals Circulating Cancer Tumor Cells (CTCs) and Circulating Cancer Stem Cells (CSCs), and occasionally from biopsies of the tumor, and generates the Supportive Oligonucleotide Technique.

SOT is not a genetic therapy, as is most antisense treatments and no genotoxic (chemo) drugs are used. SOT has the ability to induce apoptosis (cell death) in the CTCs and CSCs (circulating cancer tumor & stem cells) and ALL primary and metastatic tumors (regardless of size, and is able to cross the blood brain barrier with ease). SOT will remain active in the blood stream for approximately 14-16 weeks (maybe longer) per dose. Because, the mRNA actually features a stealth like ability that keeps the body from recognizing and destroying it. SOT will work 24/7 and has no decreased efficacy with any concurrent technique except chemotherapy and/or radiation.

The end goal for this technique is to have the CTCs/CSCs (using RGCC OncoCount Test) show a maximum of <2 cells per ml and lower is always better. Also, showing stability of all tumors (based on repeat scans and/or any blood markers you may use). By the time you get to this end point we will let you know of a possible new technique on the very near horizon that may allow you even more life time protection.

The SOT has shown to be a very effective cancer support technique from clinical experience. This same methodology has been used in Europe for many years now. As of today, following extensive searches, we know of no one or other entity making this type of technique this way anywhere in the world (as of 7.21.13).

This therapy is available for private members only!